Krystal Biotech, Inc. KRYS Net Income
Net Income at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s net income?
- Krystal Biotech, Inc. (KRYS) reported net income of $55.93M in Q1 2026.
- How has Krystal Biotech, Inc.'s net income changed year-over-year?
- Krystal Biotech, Inc.'s net income increased by 56.5% year-over-year, from $35.73M to $55.93M.
- What is the long-term trend for Krystal Biotech, Inc.'s net income?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s net income has grown at a 31.0% compound annual growth rate (CAGR), from -$69.57M to $204.83M.
- What does net income mean?
- The total profit remaining after all expenses and taxes have been paid.
- How do you interpret net income?
- An increase indicates improved operational efficiency or revenue growth, while a decrease suggests rising costs or declining sales.
- How does net income compare across companies?
- The universal standard for measuring corporate profitability across all industries.